Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 30.26B | 43.15B | 35.87B | 39.33B | 49.42B |
Gross Profit | 3.99B | 8.25B | 4.63B | 5.20B | 3.40B |
EBITDA | 2.06B | 6.35B | 2.56B | 4.09B | 1.50B |
Net Income | 560.00M | 4.37B | 1.18B | 2.77B | 662.00M |
Balance Sheet | |||||
Total Assets | 58.84B | 59.56B | 55.49B | 61.50B | 66.02B |
Cash, Cash Equivalents and Short-Term Investments | 6.35B | 11.72B | 7.63B | 9.94B | 4.35B |
Total Debt | 5.41B | 4.92B | 9.10B | 15.72B | 22.43B |
Total Liabilities | 25.22B | 27.06B | 28.20B | 37.02B | 44.70B |
Stockholders Equity | 33.61B | 32.50B | 27.29B | 24.47B | 21.32B |
Cash Flow | |||||
Free Cash Flow | -5.77B | 8.26B | 5.22B | 12.10B | -408.00M |
Operating Cash Flow | -4.86B | 8.93B | 5.92B | 12.95B | 24.00M |
Investing Cash Flow | -576.00M | 2.58B | -652.00M | -4.03B | -128.00M |
Financing Cash Flow | -14.00M | -4.62B | -8.26B | -6.48B | -695.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
82 Outperform | ¥19.41B | 6.84 | 3.82% | 16.67% | 66.25% | ||
80 Outperform | ¥71.86B | 17.41 | 0.84% | 18.23% | 3.26% | ||
80 Outperform | ¥30.22B | 12.18 | 4.20% | 4.62% | 39.04% | ||
75 Outperform | $35.59B | 4.94 | 11.50% | 1.45% | 10.99% | 63.26% | |
71 Outperform | ¥266.16B | 14.97 | 8.32% | 2.79% | 6.14% | 10.82% | |
65 Neutral | ¥35.28B | 64.35 | 2.03% | 1.69% | -67.19% | ||
62 Neutral | ¥14.80B | 26.34 | 2.32% | -30.97% | -107.48% |